Wearable Health Solutions, Inc. (WHSI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 745.09 Thousand USD | -28.76% |
| 2022 | 1.04 Million USD | -24.98% |
| 2021 | 1.39 Million USD | 19.84% |
| 2020 | 1.16 Million USD | 14.61% |
| 2019 | 1.01 Million USD | 4.0% |
| 2018 | 976 Thousand USD | 14.74% |
| 2017 | 850.63 Thousand USD | -34.34% |
| 2016 | 1.29 Million USD | 12.94% |
| 2015 | 1.14 Million USD | -0.57% |
| 2014 | 1.15 Million USD | 101.44% |
| 2013 | 572.71 Thousand USD | 7.48% |
| 2012 | 532.86 Thousand USD | 17.68% |
| 2011 | 452.81 Thousand USD | -26.17% |
| 2010 | 613.35 Thousand USD | 0.0% |
| 2009 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 142.41 Thousand USD | 4.07% |
| 2024 Q2 | 127.25 Thousand USD | -10.65% |
| 2023 FY | 745.09 Thousand USD | -28.76% |
| 2023 Q1 | 216.46 Thousand USD | -4.34% |
| 2023 Q2 | 198.03 Thousand USD | -8.51% |
| 2023 Q3 | 193.74 Thousand USD | -2.17% |
| 2023 Q4 | 136.84 Thousand USD | -29.37% |
| 2022 Q3 | 212.98 Thousand USD | -30.06% |
| 2022 FY | 1.04 Million USD | -24.98% |
| 2022 Q1 | 302.87 Thousand USD | -15.49% |
| 2022 Q2 | 304.52 Thousand USD | 0.55% |
| 2022 Q4 | 226.28 Thousand USD | 6.25% |
| 2021 Q2 | 389.79 Thousand USD | 13.46% |
| 2021 FY | 1.39 Million USD | 19.84% |
| 2021 Q3 | 283.32 Thousand USD | -27.32% |
| 2021 Q4 | 358.37 Thousand USD | 26.49% |
| 2021 Q1 | 343.55 Thousand USD | -15.28% |
| 2020 Q4 | 405.52 Thousand USD | 30.91% |
| 2020 FY | 1.16 Million USD | 14.61% |
| 2020 Q3 | 309.77 Thousand USD | 39.41% |
| 2020 Q2 | 222.19 Thousand USD | -1.62% |
| 2020 Q1 | 225.85 Thousand USD | -77.75% |
| 2019 Q4 | 1.01 Million USD | 339.1% |
| 2019 Q1 | 1.01 Million USD | 215.15% |
| 2019 Q2 | 223.45 Thousand USD | -77.99% |
| 2019 Q3 | 231.16 Thousand USD | 3.45% |
| 2019 FY | 1.01 Million USD | 4.0% |
| 2018 Q3 | 487.86 Thousand USD | 730.34% |
| 2018 FY | 976 Thousand USD | 14.74% |
| 2018 Q4 | 322.08 Thousand USD | -33.98% |
| 2018 Q2 | 58.75 Thousand USD | -45.24% |
| 2018 Q1 | 107.29 Thousand USD | -45.52% |
| 2017 Q1 | 246.42 Thousand USD | -17.53% |
| 2017 Q2 | 208.84 Thousand USD | -15.25% |
| 2017 Q3 | 198.41 Thousand USD | -4.99% |
| 2017 Q4 | 196.95 Thousand USD | -0.73% |
| 2017 FY | 850.63 Thousand USD | -34.34% |
| 2016 Q3 | 325.09 Thousand USD | -5.13% |
| 2016 Q4 | 298.79 Thousand USD | -8.09% |
| 2016 FY | 1.29 Million USD | 12.94% |
| 2016 Q1 | 328.94 Thousand USD | -7.44% |
| 2016 Q2 | 342.68 Thousand USD | 4.18% |
| 2015 Q1 | 271 Thousand USD | -29.65% |
| 2015 Q2 | 241.07 Thousand USD | -11.04% |
| 2015 Q3 | 279.62 Thousand USD | 15.99% |
| 2015 Q4 | 355.39 Thousand USD | 27.09% |
| 2015 FY | 1.14 Million USD | -0.57% |
| 2014 Q1 | 264.86 Thousand USD | 144.7% |
| 2014 Q4 | 385.19 Thousand USD | 56.01% |
| 2014 Q2 | 256.73 Thousand USD | -3.07% |
| 2014 FY | 1.15 Million USD | 101.44% |
| 2014 Q3 | 246.9 Thousand USD | -3.83% |
| 2013 Q3 | 179.11 Thousand USD | 27.29% |
| 2013 Q2 | 140.71 Thousand USD | 47.46% |
| 2013 Q1 | 95.42 Thousand USD | -74.18% |
| 2013 FY | 572.71 Thousand USD | 7.48% |
| 2013 Q4 | 108.23 Thousand USD | -39.57% |
| 2012 Q3 | 45.62 Thousand USD | -42.64% |
| 2012 Q2 | 79.54 Thousand USD | 108.7% |
| 2012 Q4 | 369.57 Thousand USD | 710.05% |
| 2012 FY | 532.86 Thousand USD | 17.68% |
| 2012 Q1 | 38.11 Thousand USD | 11.97% |
| 2011 Q4 | 34.04 Thousand USD | -84.35% |
| 2011 FY | 452.81 Thousand USD | -26.17% |
| 2011 Q3 | 217.44 Thousand USD | 103.79% |
| 2011 Q2 | 106.7 Thousand USD | 12.75% |
| 2011 Q1 | 94.63 Thousand USD | 81.64% |
| 2010 Q2 | 332.82 Thousand USD | 0.0% |
| 2010 FY | 613.35 Thousand USD | 0.0% |
| 2010 Q4 | 52.1 Thousand USD | -77.19% |
| 2010 Q3 | 228.42 Thousand USD | -31.37% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q1 | -2160.00 USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 100.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | 76.654% |
| Ansell Limited | 1.61 Billion USD | 99.954% |
| Ansell Limited | 1.61 Billion USD | 99.954% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | 99.596% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -451.696% |
| Psykey, Inc. | 419.29 Thousand USD | -77.7% |
| ConvaTec Group Plc | 2.19 Billion USD | 99.966% |
| ConvaTec Group Plc | 2.14 Billion USD | 99.965% |
| Encision Inc. | 6.58 Million USD | 88.687% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | 59.171% |
| LifePoint, Inc. | -18.5 Thousand USD | 4127.53% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | 89.064% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | 3.485% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | 24.45% |
| Reflect Scientific, Inc. | 1.08 Million USD | 31.02% |
| SmileDirectClub, Inc. | 470.74 Million USD | 99.842% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 99.96% |
| SheerVision, Inc. | 3.49 Million USD | 78.708% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | 46.253% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -614.491% |